Tens of millions of people around the world suffer from Alzheimer’s Disease There is no cure, treatments are limited and more and more people are dying of the devastating brain disease Scientists at Yale University wanted to find a way to disrupt the early protein binding that leads to the disease They discovered that an old antibiotic in a...
Tag: <span>Alzheimer’s disease</span>
Post
Alzheimer’s Disease and Gingko Biloba
What is Ginkgo Biloba? Ginkgo biloba is a tree that is native to China and has been used in traditional Chinese medicine and cuisine for centuries. Extracts of Ginkgo biloba are often sold as food supplements with potential medicinal uses ranging from treating high blood pressure to altitude sickness. The efficacy of Ginkgo extracts for...
Post
Wiring diagram of the brain provides a clearer picture of brain scan data
Already affecting more than five million Americans older than 65, Alzheimer’s disease is on the rise and expected to impact more than 13 million people by 2050. Over the last three decades, researchers have relied on Neuroimaging—brain scans such as magnetic resonance imaging (MRI) or positron emission tomography (PET) – to study Alzheimer’s disease and...
Post
New PET tracer identified for imaging tau in Alzheimer’s disease patients
Checkerboard plot showing 18F-RO-948-positivity results (black cells: bilaterally positive; gray cells: unilaterally positive) of anterior and posterior Braak regions (19), and estimated Braak stages (right column) (20). esV = extrastriatal …more In the diagnosis of Alzheimer’s disease and the search for effective treatments, tau tangles in the brain have joined amyloid build-up as markers of...
Post
Study points to novel epigenetic target for Alzheimer’s Disease
A research team at the University of Miami Miller School of Medicine’s Center for Therapeutic Innovation (CTI) has identified a novel epigenetic drug target to simultaneously normalize multiple deficits in Alzheimer’s disease (AD), the most common form of dementia in the elderly and the sixth leading cause of death in the U.S., according to the...
Post
Retiring Later May Be One Way to Lower Your Alzheimer’s Risk
Experts say continuing to work can keep you mentally sharp. So can exercise and engaging with family and friends. Image: Being at a job can challenge your brain and help lower your Alzheimer’s risk, experts say. Getty Images Crossword puzzles are fine, but you probably should be doing more to stimulate your brain to help...
Post
Scientists create new map of brain region linked to Alzheimer’s disease
Curing some of the most vexing diseases first requires navigating the world’s most complex structure—the human brain. So, USC scientists have created the most detailed atlas yet of the brain‘s memory bank. Cartographers of the cranium, a USC research team has illustrated the internal circuitry of the hippocampus in detail that would make the great...
Post
Age, sex, APOE genotype identify alzheimer’s, dementia risk
(HealthDay)—Age, sex and apolipoprotein E (APOE) genotype can identify groups at high 10-year risk for Alzheimer’s disease and all dementia, according to a study published Sept. 4 in CMAJ, the journal of the Canadian Medical Association. Katrine L. Rasmussen, M.D., Ph.D., from Copenhagen University Hospital in Denmark, and colleagues used data from the Copenhagen General Population...
Post
Existing liver drug can help treat Alzheimer’s
Research reveals that an existing drug used to treat liver disease could also be employed in Alzheimer’s disease therapy. The drug “heals” malfunctioning elements at cellular level. Alzheimer’s Disease is the most common type of dementia. It affects around 5.7 million people in the United States and about 46.8 million people worldwide. An existing drug for...
Post
Alzheimer’s-associated tau protein disrupts molecular transport within neurons
Abnormal form of tau interacts with structure handling transport between nucleus and cytoplasm MASSACHUSETTS GENERAL HOSPITAL A multi-institutional study led by investigators at Massachusetts General Hospital (MGH) and Johns Hopkins School of Medicine has found how the abnormal form of tau that accumulates in the neurofibrillary tangles that characterize Alzheimer’s disease can disrupt the normal...